These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3085875)

  • 21. A synthesis-driven structure revision of berkelic acid methyl ester.
    Buchgraber P; Snaddon TN; Wirtz C; Mynott R; Goddard R; Fürstner A
    Angew Chem Int Ed Engl; 2008; 47(44):8450-4. PubMed ID: 18816540
    [No Abstract]   [Full Text] [Related]  

  • 22. Structure, molecular genetics, and function of complement control proteins: an update.
    Volanakis JE
    Year Immunol; 1988; 3():275-90. PubMed ID: 3327315
    [No Abstract]   [Full Text] [Related]  

  • 23. Synthesis and anticonvulsant activity of new 4-thiazolidone and 4-thiazoline derivatives.
    Ergenç N; Capan G
    Farmaco; 1994 Jun; 49(6):449-51. PubMed ID: 8074788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
    Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis, partition coefficients and antibacterial activity of 3'-phenyl (substituted)-6'-aryl-2' (1H)-cis-3',3'a-dihydrospiro [3-H-indole-3,5'-pyrazolo (3',4'-d)-thiazolo-2-(1H)-ones].
    Sahu SK; Banerjee M; Mishra SK; Mohanta RK; Panda PK; Misro PK
    Acta Pol Pharm; 2007; 64(2):121-6. PubMed ID: 17665861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
    Giclas PC
    J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and in-vitro activity of novel 1beta-methylcarbapenems having spiro[2,4]heptane moieties.
    Park HB; Jo NH; Hong JH; Choi JH; Cho JH; Yoo KH; Oh CH
    Arch Pharm (Weinheim); 2007 Oct; 340(10):530-7. PubMed ID: 17849445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]- 3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2" -dioxide) derivatives with anti-HIV-1 and anti-human-cytomegalovirus activity.
    de Castro S; Lobatón E; Pérez-Pérez MJ; San-Félix A; Cordeiro A; Andrei G; Snoeck R; De Clercq E; Balzarini J; Camarasa MJ; Velázquez S
    J Med Chem; 2005 Feb; 48(4):1158-68. PubMed ID: 15715482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and classical pathway Complement inhibitory activity of C7-functionalized filifolinol derivatives, inspired in K-76 COOH.
    Larghi EL; Operto MA; Torres R; Kaufman TS
    Eur J Med Chem; 2012 Sep; 55():74-84. PubMed ID: 22835722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin binding and augmentation of C1 inhibitor activity.
    Caldwell EE; Andreasen AM; Blietz MA; Serrahn JN; VanderNoot V; Park Y; Yu G; Linhardt RJ; Weiler JM
    Arch Biochem Biophys; 1999 Jan; 361(2):215-22. PubMed ID: 9882449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-species function of the pig C1 esterase inhibitor.
    Koboyashi C; Matsunami K; Omori T; Nakahata K; Nakatsu S; Xu H; Gao C; Ihara Y; Fukuzawa M; Miyagawa S
    Transplant Proc; 2006 Dec; 38(10):3321-2. PubMed ID: 17175261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of activation of human T lymphocytes by the complement C1 esterase inhibitor.
    Eriksson H; Sjögren HO
    Immunology; 1995 Oct; 86(2):304-10. PubMed ID: 7490133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Episodes of angioedema in children with C1 esterase inhibitor deficiency].
    Hemels MA; Geelen SP; Hoekstra MO; Meijer Y
    Ned Tijdschr Geneeskd; 2006 Mar; 150(11):631-4. PubMed ID: 16610507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and anticonvulsant activity of new 3-[(2-furyl)carbonyl]amino-4-thiazolidinone and 2-[(2-furyl)carbonyl]hydrazono-4-thiazoline derivatives.
    Capan G; Ulusoy N; Ergenç N; Cevdet Ekinci A; Vidin A
    Farmaco; 1996 Nov; 51(11):729-32. PubMed ID: 9035380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C1 esterase inhibitor: new preparation. A major advance in emergency treatment of hereditary angioneurotic oedema.
    Prescrire Int; 2001 Jun; 10(53):67-70. PubMed ID: 11718165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the role of the C1-esterase inhibitor in cold urticaria.
    Nilsson T; Bäck O
    Acta Derm Venereol; 1984; 64(3):197-202. PubMed ID: 6204479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic and biological studies on the spiro-mamakone system.
    Murphy AC; Devenish SR; Muscroft-Taylor AC; Blunt JW; Munro MH
    Org Biomol Chem; 2008 Oct; 6(20):3854-62. PubMed ID: 18843418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C1 inactivator-C1s complexes in inflammatory joint disease.
    Inman RD; Harpel PC
    Clin Exp Immunol; 1983 Sep; 53(3):521-8. PubMed ID: 6604603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and structure-activity relationships of spirohydantoin-derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1).
    Rowbottom MW; Vickers TD; Tamiya J; Zhang M; Dyck B; Grey J; Schwarz D; Heise CE; Hedrick M; Wen J; Tang H; Wang H; Fisher A; Aparicio A; Saunders J; Goodfellow VS
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2171-8. PubMed ID: 17350839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.